Inhibikase Therapeutics’s (IKT) 10-Day exponential moving average is 1.75, while Inhibikase Therapeutics’s (IKT) share price is $1.76, making it a Buy.
Inhibikase Therapeutics’s (IKT) 100-Day exponential moving average is 1.75, while Inhibikase Therapeutics’s (IKT) share price is $1.76, making it a Buy.
Inhibikase Therapeutics’s (IKT) stock price is $1.76 and Inhibikase Therapeutics’s (IKT) 50-day simple moving average is 1.78, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) stock price is $1.76 and Inhibikase Therapeutics’s (IKT) 100-day simple moving average is 1.71, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) stock price is $1.76 and Inhibikase Therapeutics’s (IKT) 200-day simple moving average is 1.70, creating a Buy signal.